BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 8165871)

  • 21. TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.
    Murata T; Sato Y; Nakayama S; Kudoh A; Iwahori S; Isomura H; Tajima M; Hishiki T; Ohshima T; Hijikata M; Shimotohno K; Tsurumi T
    J Biol Chem; 2009 Mar; 284(12):8033-41. PubMed ID: 19164291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoic acid is a negative regulator of the Epstein-Barr virus protein (BZLF1) that mediates disruption of latent infection.
    Sista ND; Pagano JS; Liao W; Kenney S
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3894-8. PubMed ID: 8387200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication.
    Zhang Q; Hong Y; Dorsky D; Holley-Guthrie E; Zalani S; Elshiekh NA; Kiehl A; Le T; Kenney S
    J Virol; 1996 Aug; 70(8):5131-42. PubMed ID: 8764021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.
    Lear AL; Rowe M; Kurilla MG; Lee S; Henderson S; Kieff E; Rickinson AB
    J Virol; 1992 Dec; 66(12):7461-8. PubMed ID: 1331531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites.
    Ragoczy T; Miller G
    J Virol; 2001 Jun; 75(11):5240-51. PubMed ID: 11333906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
    Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
    J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction.
    Borras AM; Strominger JL; Speck SH
    J Virol; 1996 Jun; 70(6):3894-901. PubMed ID: 8648726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent.
    Zhang L; Chiu J; Lin JC
    DNA Cell Biol; 1998 Sep; 17(9):735-42. PubMed ID: 9778032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation.
    Baumann M; Mischak H; Dammeier S; Kolch W; Gires O; Pich D; Zeidler R; Delecluse HJ; Hammerschmidt W
    J Virol; 1998 Oct; 72(10):8105-14. PubMed ID: 9733851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation.
    Zhang W; Han D; Wan P; Pan P; Cao Y; Liu Y; Wu K; Wu J
    Sci Rep; 2016 Oct; 6():34543. PubMed ID: 27708396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.
    Wu FY; Wang SE; Chen H; Wang L; Hayward SD; Hayward GS
    J Virol; 2004 May; 78(9):4847-65. PubMed ID: 15078966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome.
    Dunn LEM; Lu F; Su C; Lieberman PM; Baines JD
    J Virol; 2023 Feb; 97(2):e0189422. PubMed ID: 36744959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
    Yu X; Wang Z; Mertz JE
    PLoS Pathog; 2007 Dec; 3(12):e194. PubMed ID: 18085824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site.
    Zetterberg H; Jansson A; Rymo L; Chen F; Karlsson A; Klein G; Brodin B
    J Gen Virol; 2002 Aug; 83(Pt 8):2007-2014. PubMed ID: 12124465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.
    Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC
    Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus BZLF1 transactivator is a negative regulator of Jun.
    Sato H; Takeshita H; Furukawa M; Seiki M
    J Virol; 1992 Aug; 66(8):4732-6. PubMed ID: 1321269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BZLF1 interacts with chromatin remodelers promoting escape from latent infections with EBV.
    Schaeffner M; Mrozek-Gorska P; Buschle A; Woellmer A; Tagawa T; Cernilogar FM; Schotta G; Krietenstein N; Lieleg C; Korber P; Hammerschmidt W
    Life Sci Alliance; 2019 Apr; 2(2):. PubMed ID: 30926617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
    Ellis AL; Wang Z; Yu X; Mertz JE
    J Virol; 2010 Jun; 84(12):6139-52. PubMed ID: 20375168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.